Short-term post-COVID-19 symptoms in 21,012 patients: a cross-sectional study

Objectives: This study aimed to clarify the short-term symptoms, duration, and influencing factors in people recovering from coronavirus disease 2019 (COVID-19) after China’s dynamic zero-COVID-19 policy was implemented in December 2022. Methods: We included data from a large-scale on-line survey conducted in China between January 14 and February 1, 2023. Participants were individuals of all ages. Chi-squared tests and multivariate logistic regression analyses were performed to identify factors associated with different symptoms. Results: Overall, 21,012 patients from seven regions of China were included in this study (female: 71.22%). For most patients, the period from symptom onset to a negative nucleic acid test result was ≤10 days (72.33%). The distribution of symptoms varied at different times, with respiratory (1–4 weeks) and psychocardiology (5–8 weeks) symptoms being the most common. Multivariate analysis identified male sex, no comorbidity, and living in northeast and northwest China (compared with central China) as independent factors associated with a lower risk of symptoms, while age (41–60 years) was a possible risk factor (compared with 18–40 years). Conclusions: Short-term respiratory and psychocardiology symptoms were the most common after COVID-19 recovery. Sex, age, geographical region, and comorbidities were potential influencing factors for the development of short-term symptoms.

Authors

Institutions

Publication Details

Journal
Acupuncture and Herbal Medicine
Published
2025-09-01
DOI
https://doi.org/10.1097/hm9.0000000000000166
Primary Topic
Long-Term Effects of COVID-19
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Short-term post-COVID-19 symptoms in 21,012 patients: a cross-sectional study

Chenyao Zhang, Jingqing Hu, Shuguang Yu, Yan Xing et al.
Acupuncture and Herbal Medicine
Long-Term Effects of COVID-19
article

Short-term post-COVID-19 symptoms in 21,012 patients: a cross-sectional study

Chenyao Zhang, Jingqing Hu, Shuguang Yu, Yan Xing, Lujia Cao, Xiaolei Wu, Wentai Pang, Wenliang Lyu, Junhua Zhang, Wenke Zheng, Wei Liu, Liu Li, Hui Wang, Zhimin Yang, Xinyao Jin, Ming Yang, Yan Shi, Bo Pang, Candong Li, Chuanchi Wang
article en

Abstract

Objectives: This study aimed to clarify the short-term symptoms, duration, and influencing factors in people recovering from coronavirus disease 2019 (COVID-19) after China’s dynamic zero-COVID-19 policy was implemented in December 2022. Methods: We included data from a large-scale on-line survey conducted in China between January 14 and February 1, 2023. Participants were individuals of all ages. Chi-squared tests and multivariate logistic regression analyses were performed to identify factors associated with different symptoms. Results: Overall, 21,012 patients from seven regions of China were included in this study (female: 71.22%). For most patients, the period from symptom onset to a negative nucleic acid test result was ≤10 days (72.33%). The distribution of symptoms varied at different times, with respiratory (1–4 weeks) and psychocardiology (5–8 weeks) symptoms being the most common. Multivariate analysis identified male sex, no comorbidity, and living in northeast and northwest China (compared with central China) as independent factors associated with a lower risk of symptoms, while age (41–60 years) was a possible risk factor (compared with 18–40 years). Conclusions: Short-term respiratory and psychocardiology symptoms were the most common after COVID-19 recovery. Sex, age, geographical region, and comorbidities were potential influencing factors for the development of short-term symptoms.

Acupuncture and Herbal MedicineVol. 5(3)
Jiangxi University of Traditional Chinese Medicine (CN), Guangzhou University of Chinese Medicine (CN), Fujian University of Traditional Chinese Medicine (CN), Tianjin University of Traditional Chinese Medicine (CN), Shandong University of Traditional Chinese Medicine (CN), Hubei University of Chinese Medicine (CN), National Medical Products Administration (CN), State Administration of Traditional Chinese Medicine of the People's Republic of China (CN), Liaoning University of Traditional Chinese Medicine (CN), Hebei University of Chinese Medicine (CN), Chengdu University of Traditional Chinese Medicine (CN), Shaanxi University of Chinese Medicine (CN), Core Laboratories (United States) (US)
Openalex Percentile: Top 66%
Long-Term Effects of COVID-19
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.